Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/3010% above fair value
$259.60−0.05 (-0.02%)
Close on Nov 13, 2026Market cap $28.56BP/E 25.9Yield –
Quest Diagnostics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Quest Diagnostics's enterprise value was $34.42B on Nov 11, 2026, against $26.80B a year earlier. Over the last 5 years it ranged from $18.17B to $34.42B, with a median of $21.58B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $34.42B | +37.6% |
| 2025 | Dec 31, 2025 | $25.02B | +11.8% |
| 2024 | Dec 31, 2024 | $22.38B | +12.7% |
| 2023 | Dec 29, 2023 | $19.86B | -10.6% |
| 2022 | Dec 30, 2022 | $22.21B | -13.5% |
| 2021 | Dec 31, 2021 | $25.68B | +33.6% |
| 2020 | Dec 31, 2020 | $19.22B | +5.4% |
| 2019 | Dec 31, 2019 | $18.24B | +21.0% |
| 2018 | Dec 31, 2018 | $15.08B | -12.5% |
| 2017 | Dec 29, 2017 | $17.24B | +3.8% |
| 2016 | Dec 30, 2016 | $16.61B | +18.9% |
| 2015 | Dec 31, 2015 | $13.97B | +3.7% |
| 2014 | Dec 31, 2014 | $13.48B | +16.3% |
| 2013 | Dec 31, 2013 | $11.59B | -8.7% |
| 2012 | Dec 31, 2012 | $12.69B | -8.1% |
| 2011 | Dec 30, 2011 | $13.80B | +9.6% |
| 2010 | Dec 31, 2010 | $12.59B | +10.9% |
| 2009 | Dec 31, 2009 | $11.35B | – |
See a number that looks wrong?